Immune response in melanoma: an in-depth analysis of the primary tumor and corresponding sentinel lymph node-Reference-Cited by-同舟云学术

Immune response in melanoma: an in-depth analysis of the primary tumor and corresponding sentinel lymph node

Published:2012-03-16 Issue:7 Volume:25 Page:1000-1010
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Ma Michelle W,Medicherla Ratna C,Qian Meng,Vega-Saenz de Miera Eleazar,Friedman Erica B,Berman Russell S,Shapiro Richard L,Pavlick Anna C,Ott Patrick A,Bhardwaj Nina,Shao Yongzhao,Osman Iman,Darvishian Farbod

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/modpathol201243.pdf

Reference34 articles.

1. Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999;17:976–983.

2. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009;27:6199–6206.

3. Testori A, De Salvo GL, Montesco MC, et al. Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1,313 patients (SOLISM-IMI). Ann Surg Oncol 2009;16:2018–2027.

4. Warycha MA, Zakrzewski J, Ni Q, et al. Meta-analysis of sentinel lymph node positivity in thin melanoma (≤1 mm). Cancer 2009;115:869–879.

5. Kaur C, Thomas RJ, Desai N, et al. The correlation of regression in primary melanoma with sentinel lymph node status. Clin Pathol 2008;61:297–300.

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term Outcomes of Regressed or “Burnt Out” Primary Testicular Germ Cell Tumors;Urology;2024-08

2. Influence of regression, its extent and tumor-infiltrating lymphocytes on sentinel node status, relapse, and survival in a 10-year retrospective study of melanoma patients;Melanoma Research;2024-05-13

3. Competing‐risks model for predicting the prognosis of patients with regressive melanoma based on the SEER database;Malignancy Spectrum;2024-04-08

4. High‐risk histopathologic features in local advanced conjunctival melanoma;Acta Ophthalmologica;2024-02-29

5. The Use of Immune Regulation in Treating Head and Neck Squamous Cell Carcinoma (HNSCC);Cells;2024-02-27